March 18, 2020 / 10:21 PM / 11 days ago

BRIEF-U.S. CPSC Says Novartis Recalls 100 Mg Sandimmune & Neoral Prescription Drug Blister Packages

March 18 (Reuters) - U.S. CPSC:

* U.S. CONSUMER PRODUCT SAFETY COMMISSION - NOVARTIS RECALLS 100 MG SANDIMMUNE AND NEORAL PRESCRIPTION DRUG BLISTER PACKAGES

* U.S. CONSUMER PRODUCT SAFETY COMMISSION - NOVARTIS’ RECALL DUE TO FAILURE TO MEET CHILD-RESISTANT PACKAGING REQUIREMENT; RISK OF POISONING Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below